Related references
Note: Only part of the references are listed.Analysis of IDH1 and IDH2 mutations in Japanese glioma patients
Yukihiko Sonoda et al.
CANCER SCIENCE (2009)
IDH1 Mutations at Residue p.R132 (IDH1R132) Occur Frequently in High-Grade Gliomas But Not in Other Solid Tumors
Fonnet E. Bleeker et al.
HUMAN MUTATION (2009)
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
Michael Weller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
Elaine R. Mardis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Timothy J. Ley et al.
NATURE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Characterization of acute myeloid leukemia with PTPN11 mutation:: the mutation is closely associated with NPM1 mutation but inversely related to FLT3/ITD
H-A Hou et al.
LEUKEMIA (2008)
Hypoxia-inducible factor-1α-induced differentiation of myeloid leukemic cells is its transcriptional activity independent
L-P Song et al.
ONCOGENE (2008)
RUNX1 gene mutation in primary myelodysplastic syndrome -: the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
Chien-Yuan Chen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML
K. Summers et al.
LEUKEMIA (2007)
Nucleophosmin mutations in De novo acute myeloid leukemia:: The age-dependent incidences and the stability during disease
WC Chou et al.
CANCER RESEARCH (2006)
Genetics of myeloid malignancies:: Pathogenetic and clinical implications
S Fröhling et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1α that augments transcriptional activity of CCAAT/enhancer-binding protein-α
Y Jiang et al.
LEUKEMIA (2005)
Characterization of CEBPA mutations in acute myeloid leukemia:: Most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells
LI Lin et al.
CLINICAL CANCER RESEARCH (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Share Paper
